Integer (ITGR) Stock: Buy, Sell, or Hold?
ITGR - Integer Holdings Corporation
$126.70
0.00 (0.00%)
▲
5d:
+0.07%
30d:
+0.29%
90d:
+29.95%
HOLD
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 22, 2026
TODAY
Get Alerted When ITGR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ITGR trades at premium valuation expecting 9.0% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: ITGR trades at premium valuation expecting 9.0% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$142.44
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$88.45
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ITGR is currently trading at $126.70, which is considered extended relative to its 30-day fair value range of $126.26 to $126.63. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.4) compared to its historical average (14.3). At these levels, the market is pricing in 9.0% annual earnings growth.
Technical Outlook: Technically, ITGR is in a strong uptrend. The price is currently testing key support at $126.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ITGR is in a strong uptrend. The price is currently testing key support at $126.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$126.26 -
$126.63
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.2%
Protect Your Profits
ITGR is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($121.80)
- BULLISH: Expecting earnings turnaround to 9.0% growth with -2.6% revenue growth
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$126.26 -
$126.63
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.50
(2.0%)
Support & Resistance Levels
Support Level
$126.52
Resistance Level
$126.83
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.45
Wall Street Target
$121.80
(-3.9%)
Revenue Growth (YoY)
-2.6%
Earnings Growth (YoY)
-33.7%
Profit Margin
7.0%
Valuation Premium vs History
+9.0% premium
PE vs Historical
18.5 vs 14.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.0%
(market-implied from PE analysis)
1-Year Target
$138.10
(+9%)
2-Year Target
$150.53
(+19%)
3-Year Target
$164.08
(+30%)
3-Yr Target (if PE normalizes)
(PE: 18→14)
PE COMPRESSION
$127.20
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 11.5%)
$188.86
(+49%)
Base:
(SPY PE: 18.4, Growth: 11.5%)
$175.41
(+38%)
Bear:
(PE: 14.3, Growth: 11.5%)
$135.99
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 34.63 | Current EPS (TTM): $3.66
Bull Case
$261.66
(+107%)
Analyst growth 87.7%, PE expands to 38.1
Base Case
$237.87
(+88%)
Market implied 87.7%, PE stable at 34.6
Bear Case
$86.19
(-32%)
Severe decline -20.0%, PE contracts to 29.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 21, 2026 5:49 PM ET
Data refreshes hourly during market hours. Next update: 6:49 PM
Data refreshes hourly during market hours. Next update: 6:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ITGR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
Advanced ITGR Option Strategies
Professional options setups generated by AI based on today's ITGR price and gamma walls.
